Sawai said looking to acquire larger Japanese rival
This article was originally published in Scrip
Executive Summary
Sawai Pharmaceutical, one of Japan's largest generics firms, has been forced to play down reports over the weekend that it is planning to acquire a domestic mid-sized company with operations in both the same sector and innovative drugs.